65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details

臨床試験数 : 482 / 薬物数 : 653 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 212

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00260702 (ClinicalTrials.gov)	November 24, 2005	1/12/2005	Omalizumab to Treat Hyper-IgE (Job's) Syndrome	Pilot Study of Omalizumab (Xolair) in Hyper IgE (Job's) Syndrome	Hyper-IgE Syndrome;Job's Syndrome	Drug: Omalizumab (Xolair)	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Completed	6 Years	76 Years	All	1	Phase 1	United States